Grants are designed to support select current and past ACS grantees specifically for the translation of their research to human testing. Mission Boost Grants (MBG) are opportunities for ACS grantees to seek additional, or "boost," resources for innovative, high-risk/high-reward projects. MBGs offer two stages of funding. The Primary Boost requires the investigator to develop outcome-specific, unequivocal milestones that reduce the risks of studying a new drug, device, or procedure in patients. The topic of study may be the same that was previously funded by the ACS grant, but it doesn't have to be. Primary MBG studies can be preclinical or clinical in nature. The Secondary Boost requires the investigator to have successfully completed the Primary Boost milestones and submitted them to the Extramural Council for permission to move forward with this grant. The investigator may apply for a Secondary Boost grant to receive support for an additional period for advancing the research to clinical testing in cancer patients. Secondary MBG studies must involve testing in cancer patients.
Deadline:
March 1, 2019
Amount and Project Period:
$240,000 over 2 years for primary mission boost; $360,000 over 18 months for secondary mission boost.
Eligibility
: Applicants must be either current or past ACS grantees who have held or currently hold Research Scholarship Grant, Mentored Research Scholar Grant, Cancer Control Career Development Awards, or Pilot and Exploratory Projects in Palliative Care Awards.
Reviewers:
ACS Extramural Research Council